105 related articles for article (PubMed ID: 2591264)
1. [A study on the pathogenesis of hepatolenticular degeneration using an in vitro model].
Chen XZ
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):133-5, 190. PubMed ID: 2591264
[TBL] [Abstract][Full Text] [Related]
2. Detection of distribution of copper inside and outside of lysosomes in cultured hepatolenticular degeneration fibroblasts by electron probe X-ray microanalysis.
Liu W; Li JY; Jin J; Zuo J
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):270-3. PubMed ID: 14599982
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight copper binding proteins in Wilson disease.
Rodo M; Wehr H; Wald I
Acta Anthropogenet; 1985; 9(1-3):63-70. PubMed ID: 3843748
[TBL] [Abstract][Full Text] [Related]
4. [Copper level and metallothionein-like Cu-binding protein in cultured skin fibroblasts from patients with Menkes' disease and Wilson's disease].
Sato M; Hayashi A; Ito H; Tojo M; Arima M
No To Shinkei; 1984 Nov; 36(11):1063-8. PubMed ID: 6525319
[TBL] [Abstract][Full Text] [Related]
5. Clinical curative effects of dimercaptosuccinic acid on hepatolenticular degeneration and the impact of DMSA on biliary trace elements.
Ren M; Yang R
Chin Med J (Engl); 1997 Sep; 110(9):694-7. PubMed ID: 9642327
[TBL] [Abstract][Full Text] [Related]
6. Studies of the copper-binding proteins in Menkes and normal cultured skin fibroblast lysates.
LaBadie GU; Beratis NG; Price PM; Hirschhorn K
J Cell Physiol; 1981 Feb; 106(2):173-8. PubMed ID: 6783668
[TBL] [Abstract][Full Text] [Related]
7. [Experiments on the pathogenesis of Wilson's disease. 4. The action of alpha-lipoic acid on the metabolism of copper and proteins in cases of hepatolenticular degeneration (recent observations)].
da COSTA S; RODRIGUES EM; da SILVA J; RELVAS ME; HALPERN MJ
Gaz Med Port; 1960; 13():706-22. PubMed ID: 13695799
[No Abstract] [Full Text] [Related]
8. [Effect of gandou decoction on copper metabolism of skin fibroblast of hepatolenticular degeneration model].
Tang Q; Yang R; Han Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jan; 20(1):37-9. PubMed ID: 11783335
[TBL] [Abstract][Full Text] [Related]
9. Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper.
Lindquist RR
Arch Pathol; 1969 Apr; 87(4):370-9. PubMed ID: 5766764
[No Abstract] [Full Text] [Related]
10. [Copper, ceruloplasmin and the pathogenesis of hepatolenticular degeneration].
Chromý K
Cas Lek Cesk; 1965 Oct; 104(43):1173-7. PubMed ID: 5322100
[No Abstract] [Full Text] [Related]
11. Prenatal and postnatal diagnosis of diseases of copper metabolism.
Chan WY; Rennert OM
Ann Clin Lab Sci; 1982; 12(5):372-80. PubMed ID: 6753725
[TBL] [Abstract][Full Text] [Related]
12. The intrahepatic distribution of copper in relation to the pathogenesis of hepatolenticular degeneration.
UZMAN LL
AMA Arch Pathol; 1957 Oct; 64(4):464-79. PubMed ID: 13457604
[No Abstract] [Full Text] [Related]
13. Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration).
Sternlieb I; Van den Hamer CJ; Morell AG; Alpert S; Gregoriadis G; Scheinberg IH
Gastroenterology; 1973 Jan; 64(1):99-105. PubMed ID: 4683859
[No Abstract] [Full Text] [Related]
14. Wilson disease: not just a copper disorder. Analysis of a Wilson disease model demonstrates the link between copper and lipid metabolism.
Huster D; Lutsenko S
Mol Biosyst; 2007 Dec; 3(12):816-24. PubMed ID: 18000558
[TBL] [Abstract][Full Text] [Related]
15. [Study on the clinical misdiagnosis of hepatolenticular degeneration].
Hu J; Lü D; Wang G
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):642-4. PubMed ID: 11798938
[TBL] [Abstract][Full Text] [Related]
16. [Perspective study on effect of gandou tablet I on biliary trace elements in treating hepatolenticular degeneration].
Hu WB; Yang RM
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Jul; 21(7):507-9. PubMed ID: 12575394
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
18. [On the localization of copper in the brain in hepatolenticular degeneration].
Levina GIa
Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):990-3. PubMed ID: 4175278
[No Abstract] [Full Text] [Related]
19. Comparison of ultrafiltration and solid phase extraction for the separation of free and protein-bound serum copper for the Wilson's disease diagnosis.
Bohrer D; Do Nascimento PC; Ramirez AG; Mendonça JK; De Carvalho LM; Pomblum SC
Clin Chim Acta; 2004 Jul; 345(1-2):113-21. PubMed ID: 15193985
[TBL] [Abstract][Full Text] [Related]
20. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
